American College of Clinical Pharmacology Response to the Institute of Medicine Report “To Err Is Human: Building a Safer Health System”

  title={American College of Clinical Pharmacology Response to the Institute of Medicine Report “To Err Is Human: Building a Safer Health System”},
  author={Linda T. Kohn and Janet M. Corrigan and Molla Sloane Donaldson},
  journal={The Journal of Clinical Pharmacology},
Boken presenterer en helhetlig strategi for hvordan myndigheter, helsepersonell, industri og forbrukere kan redusere medisinske feil. 
Translating health care imperatives and evidence into practice: the "Institute of Pharmacy" report.
  • R. Shane
  • Medicine
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
  • 2012
Thank you for the privilege of being here tonight to follow in the footsteps of the exceptionally talented and dedicated pharmacy leaders who preceded me. ASHP has provided me with numerous
Developing an optimal approach to global drug safety
Developing an optimal approach to global drug safety (Review) and a meta-analysis of existing approaches to this problem.
To Err is Human: Understanding the Data.
  • K. Parsi
  • Medicine
    The virtual mentor : VM
  • 2004
The Institute of Medicine's ground-breaking report on medical errors has helped to make patient safety a priority goal, but the findings of the report are often interpreted by the media. Virtual
The Impact of eHealth on the Quality and Safety of Health Care: A Systematic Overview
The findings of their systematic overview that assessed the impact of eHealth solutions on the quality and safety of health care are reported.
Global Research Priorities to Better Understand the Burden of Iatrogenic Harm in Primary Care: An International Delphi Exercise
Using a modified Delphi exercise, Aziz Sheikh and colleagues identify research priorities for patient safety research in primary care contexts and suggest five priorities that should be focused on in the future.
Needs and opportunities for achieving optimal outcomes from the use of medicines in hospitals and health systems.
  • Cynthia M Brennan, K. Donnelly, S. Somani
  • Medicine, Political Science
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
  • 2011
For years, the patient safety literature has been replete with articles describing the scope and breadth of adverse drug events (ADEs) across the continuum of care. In 1991, Leape[1][1] reported that
A potential for further enhancing obstetrical safety : Patient harm measurement with the global trigger tool in the south-east health-care region of Sweden
A decade of heightened awareness concerning safety issues in healthcare since the Institute of Medicine’s awakening call has resulted in a string of counteroffensive measures. The pace of improveme
Safety in Surgery
The Institute of Medicine defines patient safety as “the prevention of harm to patients”, that is “avoiding injuries to patients from the care that is intended to help them” [1].


Putting adverse drug events into perspective.
  • J. Avorn
  • Medicine, Political Science
  • 1997
The 3 articles in this issue of JAMA that deal with the prevention of adverse drug events (ADEs)1-3 illustrate that a "systems" approach to thinking about health care services can also be used for nobler purposes.
The Institute of Medicine report on medical errors--could it do harm?
  • T. Brennan
  • Medicine, Political Science
    The New England journal of medicine
  • 2000
The recent Institute of Medicine (IOM) report on the quality of care, entitled “To Err Is Human,” has awakened much of the health care system to the challenge of reducing the number of adverse events
ASHP guidelines on preventing medication errors in hospitals.
  • Medicine
    American journal of hospital pharmacy
  • 1993
The purpose of these guidelines is to provide the pharmacists with practical recommendations and best practices for preventing and mitigating patient harm from medication errors in the health-system setting and many of the ideas and principles in these guidelines may be applicable to practice settings outside of the acute care setting.
MISCELLANEOUS: Handwashing practices for the prevention of nosocomial infections
The objective was to establish an experimental procedure and show direct results that unequivocally can be assigned as safe and effective handwashing procedures for the prevention of nosocomial infections.
Clinical practice guidelines : directions for a new program
This clinical practice guidelines directions for a new program, it will really give you the good idea to be successful.
Iatrogenic illness on a general medical service at a university hospital.
Given the increasing number and complexity of diagnostic procedures and therapeutic agents, monitoring of untoward events is essential, and attention should be paid to educational efforts to reduce the risks of iatrogenic illness.
A computer-assisted management program for antibiotics and other antiinfective agents.
A computerized antiinfectives-management program linked to computer-based patient records that can assist physicians in the use of antiinfective agents and improve the quality of care and reduce costs is developed.
The safety of newly approved medicines: do recent market removals mean there is a problem?
The agency's drug review procedures and postmarketing surveillance system after a drug has been marketed are currently adequate but must continually adjust to future challenges.
Choosing a health plan: do large employers use the data?
It is suggested that purchasers are not always aware of clinical outcomes data and that measures do not meet their decision-making needs, and the variety and amount of performance information used for purchasing decisions is a barrier to effective decision making.